Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Crystal structure of UDP-glucose pyrophosphorylase from Yersinia pestis, a potential therapeutic target against plague
  2. Gibbs, Morgan E; Lountos,George; Gumpena, Rajesh; Waugh,David
  3. Acta crystallographica. Section F, Structural biology communications. 2019, Sep 01; 75(Pt 9): 608-615.
  1. 2.   Molecular alterations induced by Yersinia pestis, dengue virus and Staphylococcal enterotoxin B under severe stress
  2. Muhie, Seid; Campbell,Ross; Gautam, Aarti; Hammamieh, Rasha; Cummings, Christiano; Jett, Marti
  3. Brain, behavior, and immunity. 2019, AUG; 80: 725-741.
  1. 3.   Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model
  2. Xiao, X. D.; Zhu, Z. Y.; Dankmeyer, J. L.; Wormald, M. M.; Fast, R. L.; Worsham, P. L.; Cote, C. K.; Amemiya, K.; Dimitrov, D. S.
  3. Plos One. 2010, Oct; 5(10): 12.
  1. 4.   Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague
  2. Goodin, J. L.; Nellis, D. F.; Powell, B. S.; Vyas, V. V.; Enama, J. T.; Wang, L. C.; Clark, P. K.; Giardina, S. L.; Adamovicz, J. J.; Michiel, D. F.
  3. Protein Expression and Purification. 2007, May; 53(1): 63-79.
  1. 5.   Human cytolytic T cell recognition of Yersinia pestis virulence proteins that target innate immune responses
  2. Saikh, K. U.; Kissner, T. L.; Dyas, B.; Tropea, J. E.; Waugh, D. S.; Ulrich, R. G.
  3. Journal of Infectious Diseases. 2006, Dec; 194(12): 1753-1760.
  1. 6.   Intranasal Protollin (TM)/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection
  2. Jones, T.; Adamovicz, J. J.; Cyr, S. L.; Bolt, C. R.; Bellerose, N.; Pitt, L. M.; Lowell, G. H.; Burt, D. S.
  3. Vaccine. 2006, Mar; 24(10): 1625-1632.
  1. 7.   The case for selection at CCR5-Delta 32
  2. Sabeti, P. C.; Walsh, E.; Schaffner, S. F.; Varilly, P.; Fry, B.; Hutcheson, H. B.; Cullen, M.; Mikkelsen, T. S.; Roy, J.; Patterson, N.; Cooper, R.; Reich, D.; Altshuler, D.; O'Brien, S.; Lander, E. S.
  3. Plos Biology. 2005, NOV; 3(11): 1963-1969.
  1. 8.   Crystal structure of the Yersinia type III secretion protein YscE
  2. Phan, J.; Austin, B. P.; Waugh, D. S.
  3. Protein Science. 2005, OCT; 14(10): 2759-2763.
  1. 9.   Crystal structure of the protease-resistant core domain of Yersinia pestis virulence factor YopR
  2. Schubot, F. D.; Cherry, S.; Austin, B. P.; Tropea, J. E.; Waugh, D. S.
  3. Protein Science. 2005, JUN; 14(6): 1679-1683.
  1. 10.   Three-dimensional structure of a macromolecular assembly that regulates type III secretion in yersinia pestis
  2. Schubot, F. D.; Jackson, M. W.; Penrose, K. J.; Cherry, S.; Tropea, J. E.; Plano, G. V.; Waugh, D. S.
  3. Journal of Molecular Biology. 2005, MAR 4; 346(4): 1147-1161.
  1. 11.   Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague
  2. Powell, B. S.; Andrews, G. P.; Enama, J. T.; Jendrek, S.; Bolt, C.; Worsham, P.; Pullen, J. K.; Ribot, W.; Hines, H.; Smith, L.; Heath, D. G.; Adamovicz, J. J.
  3. Biotechnology Progress. 2005, SEP-OCT; 21(5): 1490-1510.
  1. 12.   Novel protein-protein interactions of the Yersinia pestis type III secretion system elucidated with a matrix analysis by surface plasmon resonance and mass spectrometry
  2. Swietnicki, W.; O'Brien, S.; Holman, K.; Cherry, S.; Brueggemann, E.; Tropea, J. E.; Hines, H. B.; Waugh, D. S.; Ulrich, R. G.
  3. Journal of Biological Chemistry. 2004, SEP 10; 279(37): 38693-38700.
  1. 13.   The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague
  2. Derewenda, U.; Mateja, A.; Devedjiev, Y.; Routzahn, K. M.; Evdokimov, A. G.; Derewenda, Z. S.; Waugh, D. S.
  3. Structure. 2004 12(2): 301-306.
  1. 14.   Tripeptide inhibitors of Yersinia protein-tyrosine phosphatase as potential leads for therapeutic development against plague ("black death")
  2. Lee, K.; Phan, J.; Wu, L.; Waugh, D. S.; Zhang, Z. Y.; Burke, T. R.
  3. Abstracts of Papers of the American Chemical Society. 2003 225(Part 2): U182-U182.
  1. 15.   Crystal structure of the Yersinia pestis GTPase activator YopE
  2. Evdokimov, A. G.; Tropea, J. E.; Routzahn, K. M.; Waugh, D. S.
  3. Protein Science. 2002 11(2): 401-408.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel